Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). (2021)
Attributed to:
Respiratory infections
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)01699-8
PubMed Identifier: 34480858
Publication URI: http://europepmc.org/abstract/MED/34480858
Type: Journal Article/Review
Volume: 398
Parent Publication: Lancet (London, England)
Issue: 10304
ISSN: 0140-6736